| 0 |
BLADDER INSTILLATION PROCEDURE |
24 |
0.9231 |
| 1 |
INSTILLATION SITE WARMTH |
2 |
0.2222 |
| 2 |
SEMEN LIQUEFACTION ABNORMAL |
1 |
0.0833 |
| 3 |
CHEMICAL CYSTITIS |
2 |
0.0513 |
| 4 |
URGE INCONTINENCE |
20 |
0.0230 |
| 5 |
BLADDER NEOPLASM SURGERY |
1 |
0.0072 |
| 6 |
BLADDER SPASM |
13 |
0.0069 |
| 7 |
BURNING FEET SYNDROME |
1 |
0.0040 |
| 8 |
SEMEN DISCOLOURATION |
1 |
0.0033 |
| 9 |
BLADDER IRRITATION |
2 |
0.0031 |
| 10 |
BLADDER CANCER RECURRENT |
3 |
0.0030 |
| 11 |
URETERIC CANCER |
1 |
0.0025 |
| 12 |
ORGANIC ERECTILE DYSFUNCTION |
1 |
0.0023 |
| 13 |
INFECTIVE ANEURYSM |
1 |
0.0020 |
| 14 |
INSTILLATION SITE ERYTHEMA |
1 |
0.0019 |
| 15 |
EJACULATION DELAYED |
1 |
0.0018 |
| 16 |
DOSE CALCULATION ERROR |
1 |
0.0017 |
| 17 |
PSOAS ABSCESS |
1 |
0.0016 |
| 18 |
URINARY SEDIMENT PRESENT |
1 |
0.0016 |
| 19 |
URETHRAL STENOSIS |
1 |
0.0015 |
| 20 |
BLADDER PAIN |
4 |
0.0013 |
| 21 |
INSTILLATION SITE PAIN |
3 |
0.0012 |
| 22 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 23 |
SEMEN VOLUME DECREASED |
1 |
0.0010 |
| 24 |
BLADDER DILATATION |
1 |
0.0009 |
| 25 |
PENILE SWELLING |
1 |
0.0008 |
| 26 |
HAEMORRHAGE URINARY TRACT |
2 |
0.0008 |
| 27 |
CYSTITIS NONINFECTIVE |
1 |
0.0007 |
| 28 |
CALCULUS BLADDER |
1 |
0.0007 |
| 29 |
CYSTITIS HAEMORRHAGIC |
2 |
0.0005 |
| 30 |
HAEMANGIOMA |
1 |
0.0004 |
| 31 |
INGROWING NAIL |
1 |
0.0004 |
| 32 |
EYE OEDEMA |
1 |
0.0004 |
| 33 |
URINARY INCONTINENCE |
11 |
0.0004 |
| 34 |
UNDERDOSE |
26 |
0.0004 |
| 35 |
IRITIS |
1 |
0.0003 |
| 36 |
EXPOSURE TO TOXIC AGENT |
1 |
0.0003 |
| 37 |
MICTURITION URGENCY |
3 |
0.0003 |
| 38 |
NAIL DISCOLOURATION |
1 |
0.0003 |
| 39 |
WHEELCHAIR USER |
1 |
0.0002 |
| 40 |
ACCIDENTAL EXPOSURE TO PRODUCT |
23 |
0.0002 |
| 41 |
URINE ABNORMALITY |
1 |
0.0002 |
| 42 |
DYSURIA |
8 |
0.0002 |
| 43 |
PROSTATIC DISORDER |
1 |
0.0002 |
| 44 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 45 |
INJURY ASSOCIATED WITH DEVICE |
3 |
0.0001 |
| 46 |
ONYCHOCLASIS |
1 |
0.0001 |
| 47 |
POLLAKIURIA |
6 |
0.0001 |
| 48 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 49 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 50 |
FREQUENT BOWEL MOVEMENTS |
3 |
0.0001 |
| 51 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 52 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 53 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 54 |
BURNING SENSATION |
7 |
0.0001 |
| 55 |
SCRATCH |
1 |
0.0001 |
| 56 |
RENAL PAIN |
1 |
0.0001 |
| 57 |
BACTERAEMIA |
1 |
0.0001 |
| 58 |
NOCTURIA |
1 |
0.0001 |
| 59 |
ILL-DEFINED DISORDER |
5 |
0.0001 |
| 60 |
FEELING HOT |
5 |
0.0001 |
| 61 |
CYST |
1 |
0.0001 |
| 62 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 63 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 64 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 65 |
LUNG INFECTION |
1 |
0.0001 |
| 66 |
CYSTITIS |
2 |
0.0001 |
| 67 |
LIP SWELLING |
2 |
0.0001 |
| 68 |
URINARY RETENTION |
2 |
0.0001 |
| 69 |
HAEMATURIA |
2 |
0.0001 |
| 70 |
LOCAL SWELLING |
1 |
0.0001 |
| 71 |
METASTASES TO LIVER |
1 |
0.0001 |
| 72 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 73 |
PELVIC PAIN |
1 |
0.0001 |
| 74 |
DRUG INTOLERANCE |
5 |
0.0001 |
| 75 |
BLADDER CANCER |
3 |
0.0001 |
| 76 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 77 |
SWELLING FACE |
3 |
0.0000 |
| 78 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 79 |
MELAENA |
1 |
0.0000 |
| 80 |
SNEEZING |
1 |
0.0000 |
| 81 |
CHROMATURIA |
1 |
0.0000 |
| 82 |
NEURALGIA |
1 |
0.0000 |
| 83 |
ABASIA |
1 |
0.0000 |
| 84 |
DYSGEUSIA |
3 |
0.0000 |
| 85 |
AGEUSIA |
1 |
0.0000 |
| 86 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 87 |
HAEMORRHAGE |
4 |
0.0000 |
| 88 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 89 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 90 |
ARTHROPATHY |
2 |
0.0000 |
| 91 |
EYE IRRITATION |
2 |
0.0000 |
| 92 |
INFECTION |
5 |
0.0000 |
| 93 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 94 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 95 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 96 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 97 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 98 |
NIGHT SWEATS |
1 |
0.0000 |
| 99 |
ARTHRITIS |
2 |
0.0000 |
| 100 |
PARAESTHESIA |
4 |
0.0000 |
| 101 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 102 |
DISORIENTATION |
1 |
0.0000 |
| 103 |
BLINDNESS |
1 |
0.0000 |
| 104 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 105 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 106 |
DEVICE ISSUE |
2 |
0.0000 |
| 107 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 108 |
SKIN IRRITATION |
1 |
0.0000 |
| 109 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 110 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 111 |
LUNG DISORDER |
1 |
0.0000 |
| 112 |
DRY EYE |
1 |
0.0000 |
| 113 |
CELLULITIS |
1 |
0.0000 |
| 114 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 115 |
THERAPY CESSATION |
1 |
0.0000 |
| 116 |
OEDEMA |
1 |
0.0000 |
| 117 |
MEDICATION ERROR |
1 |
0.0000 |
| 118 |
EYE PAIN |
1 |
0.0000 |
| 119 |
LETHARGY |
1 |
0.0000 |
| 120 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 121 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 122 |
CHILLS |
2 |
0.0000 |
| 123 |
STOMATITIS |
1 |
0.0000 |
| 124 |
DISCOMFORT |
1 |
0.0000 |
| 125 |
HYPERHIDROSIS |
2 |
0.0000 |
| 126 |
RHINORRHOEA |
1 |
0.0000 |
| 127 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 128 |
PAIN |
9 |
0.0000 |
| 129 |
ARTHRALGIA |
6 |
0.0000 |
| 130 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 131 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 132 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 133 |
MOBILITY DECREASED |
1 |
0.0000 |
| 134 |
RASH |
6 |
0.0000 |
| 135 |
AGITATION |
1 |
0.0000 |
| 136 |
HYPOAESTHESIA |
2 |
0.0000 |
| 137 |
HALLUCINATION |
1 |
0.0000 |
| 138 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 139 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 140 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 141 |
BACK PAIN |
3 |
0.0000 |
| 142 |
DRUG INTERACTION |
2 |
0.0000 |
| 143 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 144 |
PNEUMONIA |
4 |
0.0000 |
| 145 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 146 |
BALANCE DISORDER |
1 |
0.0000 |
| 147 |
PYREXIA |
4 |
0.0000 |
| 148 |
MUSCLE SPASMS |
2 |
0.0000 |
| 149 |
ADVERSE EVENT |
1 |
0.0000 |
| 150 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 151 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 152 |
MIGRAINE |
1 |
0.0000 |
| 153 |
CONTUSION |
1 |
0.0000 |
| 154 |
DYSPEPSIA |
1 |
0.0000 |
| 155 |
HEART RATE INCREASED |
1 |
0.0000 |
| 156 |
FLUSHING |
1 |
0.0000 |
| 157 |
SINUSITIS |
1 |
0.0000 |
| 158 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 159 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 160 |
CONSTIPATION |
2 |
0.0000 |
| 161 |
FALL |
3 |
0.0000 |
| 162 |
SEPSIS |
1 |
0.0000 |
| 163 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 164 |
DECREASED APPETITE |
2 |
0.0000 |
| 165 |
JOINT SWELLING |
1 |
0.0000 |
| 166 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 167 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 168 |
DIZZINESS |
4 |
0.0000 |
| 169 |
ASTHENIA |
3 |
0.0000 |
| 170 |
PRURITUS |
3 |
0.0000 |
| 171 |
FATIGUE |
6 |
0.0000 |
| 172 |
VISION BLURRED |
1 |
0.0000 |
| 173 |
WEIGHT DECREASED |
2 |
0.0000 |
| 174 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 175 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 176 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 177 |
VOMITING |
3 |
0.0000 |
| 178 |
NAUSEA |
5 |
0.0000 |
| 179 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 180 |
TREMOR |
1 |
0.0000 |
| 181 |
URTICARIA |
1 |
0.0000 |
| 182 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 183 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 184 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 185 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 186 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 187 |
SOMNOLENCE |
1 |
0.0000 |
| 188 |
ERYTHEMA |
1 |
0.0000 |
| 189 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 190 |
DIARRHOEA |
3 |
0.0000 |
| 191 |
OVERDOSE |
1 |
0.0000 |
| 192 |
MALAISE |
2 |
0.0000 |
| 193 |
DEPRESSION |
1 |
0.0000 |
| 194 |
FEELING ABNORMAL |
1 |
0.0000 |
| 195 |
ANXIETY |
1 |
0.0000 |
| 196 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 197 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 198 |
DYSPNOEA |
1 |
0.0000 |
| 199 |
DEATH |
1 |
0.0000 |
| 200 |
OFF LABEL USE |
1 |
0.0000 |